thursday

18

May
2017

How genomics influence clinical practice in the treatment of colorectal and gastric cancer

View full programme

Eric Van Cutsem - Gastro-Enterologist, Digestive Oncologist, University Hospitals Leuven & KU Leuven

Biography of the speaker:

Eric Van Cutsem, MD, PhD, is since 2000 full professor at the University of Leuven (Belgium). He is responsible for the division of Digestive Oncology at the University Hospitals Gasthuisberg Leuven (UZLeuven) and University of Leuven (KUL) and is board member of Leuven Cancer Institute and of the Department of Oncology at the University of Leuven.

He is member of Royal Academy of Medicine since 2015.  He is president of the Foundation against cancer (Fondation contre le cancer/ Stichting tegen kanker) since November 2016.

Professor Van Cutsem obtained his medical degree in 1983 from the University of Leuven, specializing in internal medicine and he was awarded his PhD in 1994. He holds the special Chair of Digestive Oncology at the University of Leuven and has a mandate as clinical researcher of the Fund for Scientific Research (FWO). Throughout his training he has spent several months in England, Switzerland, the USA and the Netherlands and he has been involved in clinical and research projects.

Professor Van Cutsem has published more than 467 peer-reviewed articles and more than 933 articles in WEB OF SCIENCE, Thomson Reuters (H-factor: 95; > 43000 citations) and several chapters in books on gastrointestinal cancer. His work has been published in the most respected publications such as the New England Journal of Medicine, The Lancet, JAMA, Journal of Clinical Oncology, Nature Reviews Clinical Oncology, Annals of Oncology, European Journal of Cancer, British Journal of Cancer and Gastroenterology. He is coeditor of the reference text book on gastrointestinal cancer: Principles and Practice of Gastrointestinal Oncology: second edition, 2008. He was mentioned in 2013 in Capital (French magazine) amongst top 3 experts in the world on reputation in colon cancer and mentioned in Thomson Reuters within the 1 % highest impact in his domain (http://highlycited.com).

He also co-ordinates several European and worldwide trials investigating new drugs for gastrointestinal cancer and serves on many Steering Committee and Advisory Boards.

Eric Van Cutsem is a member of several scientific organizations. He is/was a member of the Scientific Program Committee and/or educational committee of ASCO, ASCO-GI cancers symposium, ESMO, UEG and ECCO. He served for ESMO as executive board member 2011-2013 and is since 2014 on the ESMO press committee. He was secretary from 2000 to 2003 and  chair of the EORTC-GI group from 2003 to 2007 and is chairman of PETACC (Pan-European Trials on Adjuvant Colon Cancer) since 2008; he is board member of the EORTC since 2009 and president of European Society of Digestive Oncology (ESDO) and is co-chairman of the European Neuro-Endocrine Tumour Society (ENETS) registry. He was chairman of the governmental colon cancer prevention task force in Flanders, Belgium and is president of BGDO (Belgian Group Digestive Oncology), is president of FAPA (Familial Adenomatous Polyposis Association) and is executive board member of the Belgian Foundation Against Cancer. He is medical director of Europacolon (patient advocacy group).

He has been the founder (1999) of and is chair of the Scientific Committee of the ESMO GI/ World Congress on Gastrointestinal Cancer in Barcelona (in partnership with ESMO since 2005).

PLATINUM SPONSORS

No Platinum sponsor yet.
Click here and become the first Platinum sponsor.

Gold sponsors

Silver sponsors